FDA 483 OBSERVATION · #1204 OF 1,932 MOST-CITED

Periodic review of temperatures

FDA cited this observation 12 times across 12 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

What this grouping is not

An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.

BY PROGRAM AREA
Human Tissue for Transplantation12
BY FISCAL YEAR
FY20253
FY20243
FY20201
FY20192
FY20182
FY20171

How FDA worded it — real examples

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Red Star Contract Manufacturing, Inc. · Larwill, Indiana · Human Tissue for Transplantation · 2025-03-13

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Lions Eye Bank of Texas at Baylor College of Medicine · Houston, Texas · Human Tissue for Transplantation · 2025-01-29

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Team1 LLC · Jacksonville, Florida · Human Tissue for Transplantation · 2024-10-28

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Supreme Orthopedic Systems Inc · Columbia, Maryland · Human Tissue for Transplantation · 2024-08-23

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Eclipse Technology Solutions Inc · Chadds Ford, Pennsylvania · Human Tissue for Transplantation · 2024-05-01

Recorded storage temperatures were not periodically reviewed to ensure that temperatures have been within acceptable limits.

Supreme Orthopedic Systems - NOVA · Falls Church, Virginia · Human Tissue for Transplantation · 2024-04-10

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →